Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
A comprehensive biomarker assessmentincluding fasting IGF-1, cortisol, prolactin, and metabolic markerscan help providers identify whether either secretagogue aligns with individual physiology before initiating therapy
Karina W
The clinical implication is not substitution but combination: aggressive ApoB lowering to address the lipid driver of atherogenesis, paired with incretin therapy to address residual cardiometabolic and inflammatory risk
I often see this work well for individuals who are already doing many of the right thingseating well, moving their bodies, working on sleep and stressbut still feel weight-loss resistant. This slower, gentler dosing strategy can be a good fit for people with a history of GI issues like IBS or chronic constipation or who tend to be sensitive to medications in general
US$ 25.99
US$ 29.06
US$ 20.69
US$ 23.31
